IE
CLB icon

Israel Englander’s Core Laboratories CLB Stock Holding History

Israel Englander’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-142,100
Closed -$16M – 3203
2016
Q1 		$16M Buy
142,100
+58,200
+69% +$6.05M 0.04% 579
2015
Q4 		$9.12M Buy
+83,900
New +$9.6M 0.02% 973
2013
Q4 		– Sell
-2,600
Closed -$440K – 3474
2013
Q3 		$440K Buy
+2,600
New +$404K ﹤0.01% 2627

Other funds holding CLB

AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $5.91B AUM 53.97% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CAMG
CWA Asset Management Group Naples, Florida $3.28B AUM 34.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Israel Englander's CLB Position: Q2 2026 in Review

Israel Englander sold out of Core Laboratories (CLB) in Q2 2026, closing a stake of 23,802 shares — an estimated $400K sold.

Israel Englander first reported a position in CLB in Q4 2013 and held it in 32 quarters. The position peaked at $75.6M in Q2 2017. 185 funds tracked by Wall St. Rank hold CLB as of Q2 2026.

  • Israel Englander reported no remaining Core Laboratories position as of Q2 2026 after selling out during the quarter.
  • Israel Englander sold 23,802 Core Laboratories shares in Q2 2026, an estimated $400K.
  • Israel Englander first reported a position in Core Laboratories in Q4 2013 and held it in 32 quarters.
  • Israel Englander's Core Laboratories position peaked at $75.6M in Q2 2017.
  • 185 funds tracked by Wall St. Rank held Core Laboratories as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.